Skip to main content
2026 CRT Conference Main banner

CRT 2026

Beyond the Guidelines

Session:: Beyond the Guidelines | Tricuspid Repair | Replacement | Medical Therapy

TTVI (TTVR or T-TEER) for Severe Symptomatic Tricuspid Regurgitation | Does the Evidence Justify FDA Approval and Guideline Endorsement?

Sunday, March 8, 2026
4:16 PM - 4:24 PM EST
Location: Spotlight Theater

    Speaker(s)

  • Sanjay Kaul, MD

    Attending Cardiologist
    Cedars-Sinai Medical Center
    Los Angeles, California, United States

    Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Terminated, October 1, 2023); Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Bayer HealthCare: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Terminated, November 1, 2023); medtronic.: Consulting Fees (e.g., advisory boards) (Terminated, August 1, 2023); Merck Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing)